Skip to content

OptimizeRx Corp

OPRX

CIK 0001448431

← back to feed
Revenue (TTM)
$109.43M
+18.8% YoY Q1 Apr 2026
Net Income (TTM)
−$383K
+125.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.03
+124.5% YoY Q1 Apr 2026
Gross Margin
57.5%
Q1 Apr 2026
Operating Margin
3.2%
Q1 Apr 2026
Net Margin
-0.3%
Q1 Apr 2026
Free Cash Flow (TTM)
$5.32M
Q1 Apr 2026
Cash
$20.17M
Q1 Apr 2026
Total Debt
$23.34M
Q1 Apr 2026
Shares Outstanding
18.77M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings